Published in Immunity on July 01, 1998
H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med (2003) 3.55
Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J Exp Med (1999) 2.61
Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J (1999) 2.58
Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med (2004) 2.55
129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation. J Exp Med (2003) 2.26
Structure and function of immunoglobulins. J Allergy Clin Immunol (2010) 2.22
Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J Exp Med (2005) 2.13
The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity (2001) 1.98
DNA-damage repair; the good, the bad, and the ugly. EMBO J (2008) 1.89
Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J Exp Med (2005) 1.85
Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med (2000) 1.82
MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J Exp Med (2005) 1.80
A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination. J Exp Med (2004) 1.76
The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J (2005) 1.76
DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J Exp Med (2006) 1.74
AID and somatic hypermutation. Adv Immunol (2010) 1.74
Somatic hypermutation of the AID transgene in B and non-B cells. Proc Natl Acad Sci U S A (2002) 1.71
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci U S A (2001) 1.69
Different mutation signatures in DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody diversification. Proc Natl Acad Sci U S A (2005) 1.67
Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J Exp Med (2002) 1.60
DNA breaks in hypermutating immunoglobulin genes: evidence for a break-and-repair pathway of somatic hypermutation. Genetics (2001) 1.58
A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. J Exp Med (2007) 1.57
Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA. DNA Repair (Amst) (2007) 1.57
DNA polymerase theta contributes to the generation of C/G mutations during somatic hypermutation of Ig genes. Proc Natl Acad Sci U S A (2005) 1.53
A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase. J Biol Chem (2009) 1.49
DNA-cytosine deaminases: from antibody maturation to antiviral defense. DNA Repair (Amst) (2004) 1.49
AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc Natl Acad Sci U S A (2002) 1.47
Mutations occur in the Ig Smu region but rarely in Sgamma regions prior to class switch recombination. EMBO J (2003) 1.46
Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase eta during copying of a mouse immunoglobulin kappa light chain transgene. Proc Natl Acad Sci U S A (2002) 1.46
Severe attenuation of the B cell immune response in Msh2-deficient mice. J Exp Med (1999) 1.42
Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells. Immunology (2016) 1.41
DNA-dependent protein kinase activity is not required for immunoglobulin class switching. J Exp Med (2002) 1.40
Mice reconstituted with DNA polymerase beta-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their Ig genes normally. Proc Natl Acad Sci U S A (2000) 1.36
Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat Immunol (2010) 1.35
Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med (2000) 1.34
Msh2 ATPase activity is essential for somatic hypermutation at a-T basepairs and for efficient class switch recombination. J Exp Med (2003) 1.33
Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci U S A (2006) 1.30
DNA glycosylases: in DNA repair and beyond. Chromosoma (2011) 1.29
Absence of DNA polymerase eta reveals targeting of C mutations on the nontranscribed strand in immunoglobulin switch regions. J Exp Med (2004) 1.29
Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications. J Exp Med (1999) 1.28
The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J (2001) 1.28
Error-prone candidates vie for somatic mutation. J Exp Med (2000) 1.27
Altered nucleotide misinsertion fidelity associated with poliota-dependent replication at the end of a DNA template. EMBO J (2001) 1.22
Variable deletion and duplication at recombination junction ends: implication for staggered double-strand cleavage in class-switch recombination. Proc Natl Acad Sci U S A (2001) 1.21
Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha. Mol Cell Biol (2003) 1.14
Somatic immunoglobulin hypermutation. Curr Opin Immunol (2002) 1.14
Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation. Proc Natl Acad Sci U S A (2001) 1.12
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood (2008) 1.11
AIDing antibody diversity by error-prone mismatch repair. Semin Immunol (2012) 1.10
Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harb Perspect Biol (2013) 1.09
Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate. Nucleic Acids Res (2004) 1.07
The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J Exp Med (2005) 1.06
DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase. Proc Natl Acad Sci U S A (2005) 1.05
Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T. J Exp Med (2006) 1.04
Mlh1 can function in antibody class switch recombination independently of Msh2. J Exp Med (2003) 1.03
A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation. J Immunol (2006) 1.00
Uracil excision by endogenous SMUG1 glycosylase promotes efficient Ig class switching and impacts on A:T substitutions during somatic mutation. Eur J Immunol (2014) 1.00
Mismatch repair-dependent mutagenesis in nondividing cells. Proc Natl Acad Sci U S A (2012) 0.98
The mutation spectrum of purified AID is similar to the mutability index in Ramos cells and in ung(-/-)msh2(-/-) mice. Immunogenetics (2005) 0.98
Natural and man-made V-gene repertoires for antibody discovery. Front Immunol (2012) 0.98
Memory in the B-cell compartment: antibody affinity maturation. Philos Trans R Soc Lond B Biol Sci (2000) 0.97
Hijacked DNA repair proteins and unchained DNA polymerases. Philos Trans R Soc Lond B Biol Sci (2009) 0.96
Transcriptional pausing and stalling causes multiple clustered mutations by human activation-induced deaminase. FASEB J (2008) 0.96
Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philos Trans R Soc Lond B Biol Sci (2001) 0.96
Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation. J Exp Med (2009) 0.96
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol (2006) 0.95
MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites. PLoS One (2010) 0.95
Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes. Proc Natl Acad Sci U S A (2013) 0.95
Controlling somatic hypermutation in immunoglobulin variable and switch regions. Immunol Res (2010) 0.94
Involvement of Rad18 in somatic hypermutation. Proc Natl Acad Sci U S A (2006) 0.94
Three-dimensional architecture of the IgH locus facilitates class switch recombination. Ann N Y Acad Sci (2012) 0.94
DNA-dependent protein kinase inhibits AID-induced antibody gene conversion. PLoS Biol (2007) 0.94
The liaison of isotype class switch and mismatch repair: an illegitimate affair. J Exp Med (1999) 0.93
Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias. Mol Immunol (2007) 0.93
Impact of age on hypermutation of immunoglobulin variable genes in humans. J Clin Immunol (2001) 0.92
Secondary mechanisms of diversification in the human antibody repertoire. Front Immunol (2013) 0.91
Differential expression of APE1 and APE2 in germinal centers promotes error-prone repair and A:T mutations during somatic hypermutation. Proc Natl Acad Sci U S A (2014) 0.89
Immunoglobulin class switch recombination: will genetics provide new clues to mechanism? Am J Hum Genet (1999) 0.89
Combinatorial mechanisms regulating AID-dependent DNA deamination: interacting proteins and post-translational modifications. Semin Immunol (2012) 0.89
Evolution and the molecular basis of somatic hypermutation of antigen receptor genes. Philos Trans R Soc Lond B Biol Sci (2001) 0.89
Does DNA repair occur during somatic hypermutation? Semin Immunol (2012) 0.88
Hypermutation at A/T sites during G.U mismatch repair in vitro by human B-cell lysates. J Biol Chem (2008) 0.88
Mismatch-mediated error prone repair at the immunoglobulin genes. Biomed Pharmacother (2011) 0.86
Multiple transcription factor binding sites predict AID targeting in non-Ig genes. J Immunol (2013) 0.86
The role of nucleotide cofactor binding in cooperativity and specificity of MutS recognition. J Mol Biol (2008) 0.84
I. VH gene transcription creates stabilized secondary structures for coordinated mutagenesis during somatic hypermutation. Mol Immunol (2008) 0.83
UNG shapes the specificity of AID-induced somatic hypermutation. J Exp Med (2012) 0.83
Identification of murine B cell lines that undergo somatic hypermutation focused to A:T and G:C residues. Eur J Immunol (2008) 0.83
In vivo and in vitro studies of immunoglobulin gene somatic hypermutation. Philos Trans R Soc Lond B Biol Sci (2001) 0.83
Competitive repair pathways in immunoglobulin gene hypermutation. Philos Trans R Soc Lond B Biol Sci (2009) 0.83
Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair. Chem Rev (2006) 0.83
Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation. Philos Trans R Soc Lond B Biol Sci (2009) 0.83
Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase. Proc Natl Acad Sci U S A (2014) 0.82
DNA replication to aid somatic hypermutation. Adv Exp Med Biol (2007) 0.82
Generation and repair of AID-initiated DNA lesions in B lymphocytes. Front Med (2014) 0.81
Somatic hypermutation of immunoglobulin genes: lessons from proliferating cell nuclear antigenK164R mutant mice. Philos Trans R Soc Lond B Biol Sci (2009) 0.81
AID-initiated DNA lesions are differentially processed in distinct B cell populations. J Immunol (2014) 0.81
Evaluation of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and Adults. Front Immunol (2016) 0.81
Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells. MBio (2011) 0.81
Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases. DNA Repair (Amst) (2015) 0.80
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03
Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol (1979) 10.51
Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line. J Cell Biol (1982) 9.66
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell (1977) 8.46
Complete sequence of constant and 3' noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing. Cell (1978) 8.20
Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol (1976) 7.64
Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature (1979) 5.69
Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J Immunol (1978) 5.35
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 4.45
Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature (1984) 4.45
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev (1987) 4.16
Man-made antibodies. Nature (1991) 3.88
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
Origin of antibody variation. Nature (1966) 3.50
B cells acquire antigen from target cells after synapse formation. Nature (2001) 3.31
Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity (1998) 3.27
Kinetic maturation of an immune response. Nature (1991) 3.26
T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med (1978) 3.20
Linked groups of residues in immunoglobulin k chains. Nature (1967) 3.12
Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature (2001) 3.09
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
The complete amino acid sequence of a mouse kappa light chain. Biochem J (1972) 2.94
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
Molecular events during maturation of the immune response to oxazolone. Nature (1985) 2.78
TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity (1998) 2.76
mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature (1983) 2.72
Structural studies of immunoglobulin G. Nature (1969) 2.63
A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature (1985) 2.63
Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J (1999) 2.58
Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. J Mol Biol (1968) 2.57
The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J (1989) 2.48
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res (1997) 2.44
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing. Nature (1980) 2.41
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Hybrid hybridomas and their use in immunohistochemistry. Nature (1983) 2.24
Sequence analysis of immunoglobulin light chain messenger RNA. Nature (1974) 2.22
A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature (1986) 2.22
Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.16
Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing. Nucleic Acids Res (1981) 2.16
Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. J Mol Biol (1974) 2.14
Variations in amino-acid sequence near the disulphide bridges of Bence-Jones proteins. Nature (1966) 2.14
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell (1990) 2.12
Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol (1981) 2.11
Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain. Biochem J (1970) 2.11
Two classes of CD1 genes. Eur J Immunol (1989) 2.11
Structure and biological properties of immunoglobulins. Adv Immunol (1967) 2.08
The dynamic nature of the antibody repertoire. Immunol Rev (1988) 2.08
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A (2001) 1.99
Conformational isomerism and the diversity of antibodies. Proc Natl Acad Sci U S A (1994) 1.99
Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell (1978) 1.97
Original and artificial antibodies. Nature (1992) 1.97
The B-cell antigen receptor of the five immunoglobulin classes. Nature (1991) 1.97
Structure and evolution of immunoglobulins. Prog Biophys Mol Biol (1970) 1.96
Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) (2007) 1.95
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today (1993) 1.93
Reshaping human antibodies: grafting an antilysozyme activity. Science (1988) 1.92
Three rat monoclonal antibodies to human C3. Immunology (1980) 1.91
Molecular analysis of spontaneous somatic mutants. Nature (1977) 1.90
The disulphide bridges of immunoglobulin kappa-chains. Biochem J (1966) 1.89
Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell (1996) 1.88
Low cytoplasmic mRNA levels of immunoglobulin kappa light chain genes containing nonsense codons correlate with inefficient splicing. EMBO J (1994) 1.87
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
The amino acid sequence around the reactive serine residue in alkaline phosphatase from Escherichia coli. Biochem J (1964) 1.83
Letter: Fusion of two immunoglobulin-producing myeloma cells. Nature (1973) 1.83
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J (1987) 1.82
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol (2005) 1.80
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
Both DNA strands of antibody genes are hypermutation targets. Proc Natl Acad Sci U S A (1998) 1.77
Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci U S A (1986) 1.77
Recombinant antibodies possessing novel effector functions. Nature (1985) 1.76
Affinity maturation leads to differential expression of multiple copies of a kappa light-chain transgene. Nature (1993) 1.75
Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature (1990) 1.74
Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol (1996) 1.72
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum. J Cell Biol (1991) 1.70
Codon bias targets mutation. Nature (1995) 1.69
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci U S A (2001) 1.69
Control of HLA-A,B,C synthesis and expression in interferon-treated cells. EMBO J (1982) 1.69
Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens. Immunol Rev (1979) 1.67